The number one reason people do not donate blood is because they were not asked. I am asking everyone please donate blood “ You could save a life, says Chetan Makam, managing director, Haemonetics Healthcare India Private Limited
Chetan Makam,
Managing Director, Haemonetics Healthcare India
Private Limited
Please tell us about your current operations in India and your expansion plans. Haemonetics is the leader in blood management solutions. Our products span the entire blood supply chain, from the arm of donor to the arm of the patient. We provides solutions in India through a specialized network of distributors that are supported by subject matter experts in blood collection and separation, cell salvage, leucoreduction, hemostasis, and integrating various solutions into the customers practices.
As we see the growing need for safe and appropriate use of blood, which our solutions enable, we will continue to expand in a way that makes most sense for our customers, as part of the global strategy. A third of our revenues come from the Asia Pacific market, indicating the global nature of our business and the need for our products.
What are your views on the price sensitivity of the Indian market, and how does your company counter this problem? Our products deliver a value that is appreciated by the customers, whether it is getting a single donor platelet (SDP) in time, or salvaging blood for a patient in surgery, where the appropriate blood may not be available or not suitable, understanding the impact of various drugs on the coagulation profile of a patient scheduled for surgery or leucoreducing blood to make it safer for patients is the ICU/pediatric/oncology patients. For both the clinician and for Haemonetics, the focus is how these treatment/solutions do benefit the patient. Understanding the value chain is also important “ From the time a unit of blood is collected to the time it is transfused, there are a number of steps all of which cost money. The cost of the unit of blood is usually the least expensive of all the steps. Educating customers and working with them to ensure that the proper solution is incorporated in their practice is the right way forward.
What are your views on government regulation? Regulations implemented in the interest of patient safety are good and necessary. The process of registrations and other approvals with the various agencies would benefit if they could be tracked online with a secure website so that there is little ambiguity around time for these approvals.
Please comment on emerging trends and new technologies. In the area of blood management solutions – we see that a closer interaction between the blood bankers and clinicians to better manage the patients care. Leucoreduction of blood components to reduce instances of reactions to transfusions; use of therapeutic plasma exchange to treat neurological diseases; Use of dymamic coagulation tests to understand the impact of various drugs on the coagulation (clotting) profile of a patient. This allows for better transfusion decisions to be made pre-, peri- and post-operatively.
What are your companys offerings? TEG: Thromboelastograph “ Hemostasis Management Blood Track: Remote inventory management and beside transfusion management system Cell Saver: Autotransfusion system MCS+ : Multi-component system Leucoreduction filters for blood components
Like
Dislike
Be a part of Elets Collaborative Initiatives. Join Us for Upcoming Events and explore business opportunities. Like us on Facebook , connect with us on LinkedIn and follow us on Twitter , Instagram.
